These results are consistent with Zeweil et al. (2020), who demonstrated that TAA administration (200 mg/kg) for 15 weeks induced liver fibrosis in rats, characterized by increased hepatic mRNA expression of TGF-β and COL1A1 compared to control rats. Here, COL1A1 is linked to Hepatic fibrosis.